Skip to main content
FinSpry Logo
FinSpry
TVRD logo
TVRD
(NASDAQ)
Tvardi Therapeutics, Inc.
$3.02-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Tvardi Therapeutics (TVRD) Stock Price & Financial Analysis

Tvardi Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.81 - $3.04
52-Week High$43.65
52-Week Low$2.81
Open$2.90
Volume63.37K
Average Volume (3M)63.37K
Market Cap28.32M
Shares Outstanding9.38M
Price to Sales (P/S)6.99
Price to Book (P/B)1.01
EV/EBITDA-0.31
Revenue (TTM)4.02M
Net Income (TTM)-13.95M
EPS (TTM)$-1.49
Profit Margin-346.55%
Operating Margin-576.39%
Return on Equity (ROE)-50.04%
Debt to Equity0.01
50-Day MA$3.80
200-Day MA$14.47
52-Week Change-79.76%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Tvardi Therapeutics

What is the current stock price for TVRD?

As of the latest trading session, TVRD stock trades at $3.02. The 52-week range is $2.81–$43.65, with a day range of $2.81–$3.04.

What is the P/E ratio for TVRD?

The P/E ratio (Price-to-Earnings) for TVRD is shown in the Key Statistics section. This valuation metric helps compare Tvardi Therapeutics, Inc. to industry peers.

Does TVRD pay dividends?

Tvardi Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TVRD?

Based on 2 analysts, the consensus for TVRD is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TVRD?

Tvardi Therapeutics's market capitalization is $28.3M, classifying it as a micro-cap company. Tvardi Therapeutics operates in the Healthcare sector within the Biotechnology industry.